Induction, maintenance, and reversal, of streptozotocin-induced insulin- dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis)

Transplantation

Volumn 68, Issue 3, 1999, Pages 331-337

  Theriault, Betty R ^a   Thistlethwaite Jr , J R ^a   Levisetti, Matteo G ^a   Wardrip, Craig L ^a   Szot, Gregory ^a   Bruce, David S ^a   Rilo, Horatio ^a   Li, Xiantang ^a   Gray, Gary S ^b   Bluestone, Jeffrey A ^a   Padrid, Philip A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC 6076 ^*

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG SAFETY; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MACACA; NAUSEA; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; VOMITING;

ANIMALS; C-PEPTIDE; CATHETERIZATION; CHILD, PRESCHOOL; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMORAL VEIN; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY; MACACA FASCICULARIS; PANCREAS; STREPTOZOCIN; VASCULAR PATENCY;

EID: 0033567343     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199908150-00003     Document Type: Article

References (24)

1. Guide N. Molecular and cellular approaches to achieve euglycemia. RFA:DK-98-007 1997; 26.
2. Cosimi AB, Delmonico FL, Wright JK, et al. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
3. Ericzon B, Wijnen R, Kubota K, Bogaard A, Kooststra G. Diabetes induction and pancreatic transplantation in the cynomolgus monkey: methodological considerations. Transplant Int 1991; 4: 103.
4. Stegall M, Chabot J, Weber C, Reemtsma K, Hardy M. Pancreatic islet transplantation in cynomolgus monkeys. Transplantation 1989; 48: 944.
5. Mirsky I, Nelson N, Grayman I, Elgart S. Pancreatic diabetes in the monkey. Endocrinology 1937; 31: 264.
6. Scharp D, Murphy J, Newton W, Ballinger W, Lacy P. Transplantation of islet of Langerhans in diabetic rhesus monkeys. Surgery 1975; 77: 100.
7. Gray D, Warnock G, Button R, Peters M, McShane P, Morris P. Successful autotransplantation of isolated islets of Langerhans in the cynomolgus monkey. Br J Surg 1986; 73: 850.
8. Sutton R, Gray D, Burnett M, et al. Metabolic function of intra-portal and intra-splenic islet autografts in the cynomolgus monkey. Diabetes 1989; 38: 182.
9. Howard C. Streptozotocin-induced diabetes mellitus by direct pancreatic infusion in Macaca nemestrina. Diabetes 1972; 21: 138.
10. Jones C, Reynolds W, Hoganson G. Streptozotocin diabetes in the monkey; plasma levels of glucose, insulin, glucagon, and somatostatin, with corresponding morphometric analysis of islet endocrine cells. Diabetes 1980; 29: 536.
11. Takimoto G, Jones C, Lands W. Biochemical changes in rhesus monkey during the first days after streptozotocin administration are indicative of selective b cell destruction. Metabolism 1988; 37: 364.
12. Pitkin R, Reynolds W. Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 1970; 19: 85.
13. Litwak K, Cefalu W, Wagner J Streptozotocin induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation and pancreatic islets. Lab Anim Sci 1998; 48: 172.
14. Jonasson O, Jones C, Bauman A, John E, Manaligod J, Tso M. The pathophysiology of experimental insulin-deficient diabetes in the monkey. Ann Surg 1985; 20: 27.
15. Wojnicki F, Bacher J, Glowa J. Use of subcutaneous vascular access ports in rhesus monkeys. Lab Anim Sci 1994; 44: 491.
16. Levisetti M, Padrid P, Szot G, et al. Immunosuppressive effects of human CTLA4Ig in a nonhuman primate model of allogeneic pancreatic islet transplantation. J Immunol 1997; 159: 5187.
17. Lundbaek K. Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Br Med J 1962; 1507.
18. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413.
19. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989; 38 (Suppl 1): 140.
20. Kolb H, Kroncke K. Lessons from the low-dose streptozotocin model in mice. Diabetes Rev 1993; 1: 116.
21. Like A, Rossini A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415.
22. 14C)-streptozotocin in the rat. Diabetologia 1976; 12: 123.
23. 14C]-streptozotocin with special reference to the pancreatic islets. Acta Endocrinol 1978; 89: 39.
24. O'Farrell L, Griffith J, Lang M. Histologic development of the sheath that forms around long term implanted central venous catheters. J Parenteral Enteral Nutr 1996; 20: 156.